Page last updated: 2024-09-04

2,4,6-triiodoresorcinol and Influenza, Human

2,4,6-triiodoresorcinol has been researched along with Influenza, Human in 1 studies

*Influenza, Human: An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fadeeva, NI; Gerasina, SF1

Trials

1 trial(s) available for 2,4,6-triiodoresorcinol and Influenza, Human

ArticleYear
[Problems of the molecular mechanism of the effects of synthetic antiviral drugs].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 1989, Volume: 34, Issue:9

    Topics: Antiviral Agents; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Drug Evaluation, Preclinical; Fluorenes; Humans; In Vitro Techniques; Influenza A virus; Influenza, Human; Naphthoquinones; Polybrominated Biphenyls; Resorcinols; RNA, Viral; Viral Proteins

1989